PTPRK and neoplasm: Further supporting this idea, while the low abundance of PTPRκ mRNA in tumor samples is associated with lower survival rates of melanoma patients (Fig. 9b), a similar correlation was also detected in the case of patients bearing mutant but not wild-type versions of TP53 (Fig. 10b).